样式: 排序: IF: - GO 导出 标记为已读
-
Emergence of imaging technology beyond the clinical setting: Utilization of mobile health tools for at‐home testing Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-04-09 Brooke E. Starkoff, Brett S. Nickerson
Body composition assessment plays a pivotal role in understanding health, disease risk, and treatment efficacy. This narrative review explores two primary aspects: imaging techniques, namely ultrasound (US) and dual‐energy x‐ray absorptiometry (DXA), and the emergence of artificial intelligence (AI) and mobile health apps in telehealth for body composition. Although US is valuable for assessing subcutaneous
-
Artificial intelligence in clinical nutrition and dietetics: A brief overview of current evidence Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-04-09 Kiranjit Atwal
The rapid surge in artificial intelligence (AI) has dominated technological innovation in today's society. As experts begin to understand the potential, a spectrum of opportunities could yield a remarkable revolution. The upsurge in healthcare could transform clinical interventions and outcomes, but it risks dehumanization and increased unethical practices. The field of clinical nutrition and dietetics
-
Identifying nutrition risk in emergency patients: What is the most appropriate screening tool? Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-04-05 Johnny Galhano dos Santos, Camila Saueressig, Renata Wolf, Jéssica Correa dos Santos, Flávia Moraes Silva, Oellen Stuani Franzosi, Valesca Dall' Alba
BackgroundThe emergency department (ED) is the most frequent access route to the hospital. Nutrition risk (NR) screening allows the early identification of patients at risk of malnutrition. This study aimed to evaluate the feasibility and predictive validity of five different tools in EDs: Nutritional Risk Screening 2002 (NRS‐2002), Nutritional Risk Emergency 2017 (NRE‐2017), Royal Free Hospital‐Nutritional
-
Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-30 Lindsey Russell, Kayla Condo, Tiffany DeFlorville
The endocannabinoid system (ECs) is composed of multiple signaling compounds and receptors within the central and peripheral nervous system along with various organs, including the gut, liver, and skeletal muscle. The ECs has been implicated in metabolism, gut motility, and eating behaviors. The ECs is altered in disease states such as obesity. Recent studies have clarified the role of the gut microbiome
-
Clinical application of real‐time continuous glucose monitoring system during postoperative enteral nutrition therapy in esophageal cancer patients Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-24 Ranran Zhang, Ying Wu, Rui Xv, Wei Wang, Lei Zhang, Ansheng Wang, Min Li, Wei Jiang, Guoxi Jin, Xiaolei Hu
BackgroundEnteral nutrition (EN) support therapy increases the risk of abnormal blood glucose (BG). The aim of this study is to evaluate the clinical value of a real‐time continuous glucose monitoring (rt‐CGM) system in BG monitoring during postoperative EN support therapy in patients with esophageal cancer.MethodsPatients without diabetes mellitus (DM) with esophageal cancer who planned to receive
-
Dietary therapies for adult and pediatric inflammatory bowel disease Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-20 Jessica Deas, Neha D. Shah, Gauree G. Konijeti, Abigail Lundin, Olivia Lanser, Pooja Magavi, Sabina Ali
Diet is an environmental exposure implicated in the development of inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). Dietary therapy is also a tool for management of these conditions. Nutrition therapy for IBD has been shown to reduce intestinal inflammation, promote healing, and alleviate symptoms, as well as improve patients' nutrition status. Although
-
Knowledge and clinical practice of ASPEN registered dietitian nutritionist members regarding blenderized tube feedings Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-20 Terry Brown, Teresa Johnson, Allison Gomes, Hamed Samavat, Laura Byham‐Gray
BackgroundBlenderized tube feedings (BTFs) are used by patients/caregivers who report improvements in gastrointestinal tolerance compared with standard commercial feedings. Despite positive outcomes, registered dietitian nutritionists or international equivalents (RDN/Is) hesitate to recommend BTFs. We aimed to determine if an association exists between dietitian characteristics and willingness to
-
Association of in‐line digestive enzyme cartridge with enteral feeds on improvement in anthropometrics among pediatric patients with cystic fibrosis Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-17 Samarth Shrivastava, Karyn Shaw, MinJae Lee, Patricia Reitich, Stacie Hunter, Mary Klosterman, Meghana Sathe
BackgroundApproximately 85% of patients with cystic fibrosis (CF) have exocrine pancreatic insufficiency (EPI) with 10% requiring supplemental nighttime enteral tube feedings. Administration of pancreatic enzyme replacement therapy (PERT) with nighttime feedings is fraught with challenges. RELiZORB (Alcresta Therapeutics, Inc), an in‐line lipase cartridge, delivers PERT continuously with enteral feedings
-
Assessment of the risk of contamination of enteral nutrition bottles based on the simulation of home use conditions and hygiene procedures Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-16 Isabela T. F. da Silva, Caroline O. Medeiros, Jaqueline Leobet, Márcia R. Beux, Estela I. Rabito, Schaina A. P. Etgeton, Lize S. Fiori
BackgroundHome‐prepared enteral formulations are supplied to patients through enteral nutrition bottles, via a gravity bag or other container, which may be inadequately sanitized and reused more times than recommended by the manufacturer. Such procedures increase the risk of contamination and can compromise the patient's clinical outcome. In light of this, the present study aimed to assess the risk
-
Teduglutide improves liver chemistries in short bowel syndrome–associated intestinal failure: Post hoc analysis Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-16 Dejan Micic, Ian Robinson, Tanya Kidd, Brian Terreri, Bram P. Raphael
BackgroundChronic hepatic complications are common in patients with short bowel syndrome–associated intestinal failure (SBS‐IF). Teduglutide, a glucagon‐like peptide‐2 analogue, demonstrated efficacy in reducing parenteral nutrition and/or intravenous fluid dependence among patients with SBS‐IF in phase 3 clinical studies.MethodsThis was a post hoc analysis of pooled data from two separate randomized
-
Value of the modified Patient-Generated Subjective Global Assessment in indicating the need for nutrition intervention and predicting overall survival in patients with malignant tumors in at least two organs Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-09 Feifei Chong, Zhenyu Huo, Liangyu Yin, Jie Liu, Na Li, Jing Guo, Yang Fan, Mengyuan Zhang, Ling Zhang, Xin Lin, Junqiang Chen, Chunling Zhou, Suyi Li, Fuxiang Zhou, Qinghua Yao, Zengqing Guo, Min Weng, Ming Liu, Tao Li, Zengning Li, Jiuwei Cui, Wei Li, Hanping Shi, Wei Guo, Hongxia Xu
Although the Patient-Generated Subjective Global Assessment (PG-SGA) is a reference standard used to assess a patient's nutrition status, it is cumbersome to administer. The aim of the present study was to estimate the value of a simpler and easier-to-use modified PG-SGA (mPG-SGA) to evaluate the nutrition status and need for intervention in patients with malignant tumors present in at least two organs
-
Prevalence of low calf circumference in hospitalized patients classified by raw or body mass index–adjusted values Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-05 Iasmin M. de Sousa, Ana Paula Trussardi Fayh, Maria Cristina Gonzalez, Flávia M. Silva
Adiposity can influence the estimation of muscle mass using calf circumference (CC) and underestimate the frequency of low CC. An adjustment for CC using body mass index (BMI) was proposed to reduce this effect. We aimed to compare the low CC frequency in hospitalized patients when considering raw and BMI-adjusted values and explore data by sex, age, and race (white and non-white).
-
Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-06 Thais Pontello de Vries, Aline Marcos Pires, Kiara Gonçalves Dias Diniz, Anna Luiza Soares Chagas, Diego Alves Vieira, Adriana Maria Kakehasi, Vivian Marques Miguel Suen, Tatiana Bering, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Kátia de Paula Farah, Luciana Diniz Silva
BackgroundThere is neither a gold standard definition nor a universal consensus to diagnose sarcopenia in patients with chronic hepatitis C. Thus, we aimed to compare the prevalence of sarcopenia and the agreement and discrepancies between European Working Group on Sarcopenia in Older People (EWGSOP1), EWGSOP2, and Foundation for the National Institutes of Health Biomarkers Consortium Sarcopenia Project
-
-
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Catherine M. McDonald, Elizabeth K. Reid, John F. Pohl, Tatiana K. Yuzyuk, Laura M. Padula, Kay Vavrina, Kimberly Altman
Cystic fibrosis (CF) is a progressive, genetic, multi‐organ disease affecting the respiratory, digestive, endocrine, and reproductive systems. CF can affect any aspect of the gastrointestinal (GI) tract, including the esophagus, stomach, small intestine, colon, pancreas, liver, and gall bladder. GI pathophysiology associated with CF results from CF membrane conductance regulator (CFTR) dysfunction
-
Fat malabsorption: An underrecognized challenge from pancreatic disease to trauma, critical care, and beyond Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 David C. Evans
CONFLICT OF INTEREST STATEMENT David C. Evans serves as a speaker and consultant for Abbott Nutrition, Alcresta Therapeutics, Coram/CVS Optioncare, and Fresenius Kabi.
-
-
Fat malabsorption in critical illness Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 George Kasotakis, Colin Whitmore
Malnutrition in critical illness is common and is associated with significant increases in adverse outcomes. A hypermetabolic state and underfeeding both contribute to the incidence of malnutrition. Malabsorption caused by critical illness is also an important contributor to the development of malnutrition. The early provision of enteral nutrition is associated with improved outcomes. Strategies for
-
Exocrine pancreatic insufficiency and pancreatic exocrine replacement therapy in clinical practice Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Amy J. Berry, Amy Bilbo
Exocrine pancreatic insufficiency (EPI) is a complex condition that disrupts normal digestion and absorption. Patients with EPI may suffer from mild to debilitating malabsorption with a constellation of symptoms that can have a significant effect on quality of life and nutrition status. Pancreatic enzyme replacement therapy (PERT) is effective and safe to treat EPI and is the standard of care for this
-
Fat malabsorption in pancreatic cancer: Pathophysiology and management Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Gretchen Murray, Mitchell L. Ramsey, Phil A. Hart, Kristen M. Roberts
Exocrine pancreatic insufficiency (EPI) is common in pancreatic ductal adenocarcinoma (PDAC) and may lead to significant nutrition compromise. In the setting of cancer cachexia and gastrointestinal toxicities of cancer treatments, untreated (or undertreated) EPI exacerbates weight loss, sarcopenia, micronutrient deficiencies, and malnutrition. Together, these complications contribute to poor tolerance
-
Exocrine pancreatic insufficiency and fat malabsorption related to pancreatectomy and other gastrointestinal surgery: A narrative review Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Gareth Morris‐Stiff
Surgical resection is the mainstay of treatment for patients with tumors of the pancreas. There are a number of well‐recognized complications that account for the significant morbidity associated with the operation, including exocrine pancreatic insufficiency (EPI). Patients with pancreatic cancer commonly have evidence of EPI prior to surgery, and this is exacerbated by an operation, the extent of
-
Fat malabsorption in short bowel syndrome: A review of pathophysiology and management Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Thomas I. Hirsch, Sarah Z. Wang, Scott C. Fligor, Mikayla Quigley, Kathleen M. Gura, Mark Puder, Savas T. Tsikis
Fat malabsorption is central to the pathophysiology of short bowel syndrome (SBS). It occurs in patients with insufficient intestinal surface area and/or function to maintain metabolic and growth demands. Rapid intestinal transit and impaired bile acid recycling further contribute to fat malabsorption. A significant portion of patients require parenteral nutrition (PN) for their survival but may develop
-
Fat digestion and absorption: Normal physiology and pathophysiology of malabsorption, including diagnostic testing Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-03-02 Endashaw Omer, Cristina Chiodi
Fat digestion and absorption play crucial roles in maintaining energy homeostasis and supporting essential physiological functions. The initial stage of fat digestion occurs in the stomach, where gastric lipase begins the hydrolysis of triglycerides. However, most fat digestion takes place in the small intestine via pancreatic enzymes and bile salts. Emulsification of fat by bile acids facilitates
-
Nutrition and outcomes in venovenous extracorporeal membrane oxygenation: An observational cohort study Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-20 Stacy Pelekhaty, Julie Gessler, Siddhartha Dante, Nicholas Rector, Samuel Galvagno, Stephen Stachnik, Joseph Rabin, Ali Tabatabai
BackgroundOverfeeding and underfeeding are associated with negative outcomes during critical illness. The purpose of this retrospective study was to assess the association between nutrition intake and outcomes for patients receiving venovenous (VV) extracorporeal membrane oxygenation (ECMO).MethodsAdults who received VV ECMO August 2017 to June 2020 were screened. Patients with <3 ECMO nutrition support
-
Completion of a Nutrition‐Focused Physical Exam with hospitalized adults and pediatric patients: Secondary analysis of a prospective cohort study Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-19 Elizabeth Yakes Jimenez, Erin Lamers‐Johnson, Julie M. Long, Beth A. Mordarski, Xingya Ma, Alison Steiber
BackgroundNutrition‐Focused Physical Exam (NFPE) feasibility is not well‐studied. We describe registered dietitian nutritionist (RDN)–reported NFPE completion for hospitalized adult and pediatric patients overall and by assessment parameters.MethodsTrained RDNs systematically conducted NFPEs for hospitalized adult and pediatric patients during the Academy of Nutrition and Dietetics and American Society
-
Evidence-based practice attitudes and nutrition support guideline knowledge between holders and nonholders of the Certified Nutrition Support Clinician credential Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-17 Lea Steiner, Joachim Sackey, Deborah Cohen, Rebecca Brody
Clinical practice frequently changes, and professionals should stay abreast of evidence-based practice (EBP) guidelines. Negative attitudes towards EBP are a barrier to guideline adoption. This study explored EBP attitudes and knowledge of a complex nutrition support clinical case scenario of individuals holding or not holding the Certified Nutrition Support Clinician (CNSC) credential.
-
Nutrition therapy in critically ill patients with severe acute pancreatitis Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-15 Jia-kui Sun, Cheng Lv, Lin Gao, Wenjian Mao, Weiqin Li, Lu Ke
A significant proportion of patients (10%–20%) with acute pancreatitis develop severe acute pancreatitis characterized by pancreatic necrosis, systemic inflammation, and organ failure, commonly requiring intensive care unit (ICU) admission. In this specific population, nutrition therapy is more challenging than that in the general ICU population, primarily because of inevitable gastrointestinal involvement
-
Disordered eating behaviors in pediatric patients with inflammatory bowel disease in remission or mild-moderate disease activity Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-07 Maggie Vickers, John Whitworth, Lybil Mendoza Alvarez, Michelle Bowden
Inflammatory bowel disease (IBD) is a chronic, autoimmune disorder that affects the gastrointestinal tract. Disordered eating describes irregular eating behaviors that may be a precursor to an eating disorder diagnosis. Higher rates of disordered eating have been described in chronic diseases. Screening for disordered eating is not performed in pediatric patients with IBD. The goal of this longitudinal
-
High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-06 Ilkay Ergenc, Chasan Ismail Basa, Alper Uzum, Sevval Sahin, Haluk Tarık Kani, Rahmi Aslan, Aslı Tufan, Özgür Kasımay, Özlen Atuğ, Yeşim Özen Alahdab
This study aimed to determine the prevalence of probable sarcopenia and sarcopenia in patients with inflammatory bowel disease (IBD) by using the European Working Group on Sarcopenia in Older People (EWGSOP2) diagnostic criteria.
-
Global Leadership Initiative on Malnutrition criteria in older adults who are institutionalized: Agreement with the Subjective Global Assessment and its impact on 5-year mortality Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-02-05 Guilherme F. Graciano, Isabella R. Souza, Maria Isabel T. D. Correia, Lucilene R. Anastácio, Bárbara C. Santos
This study aimed to assess the prevalence of malnutrition according to Subjective Global Assessment (SGA), Mini Nutritional Assessment–Full Form (MNA-FF), and different combinations of the Global Leadership Initiative on Malnutrition (GLIM) criteria in older adults who are institutionalized, and the impact of malnutrition on 5-year mortality.
-
A longitudinal study to determine if all critically ill patients should be considered at nutrition risk or is there a highly accurate screening tool to be adopted? Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-01-28 Elisa L. Razzera, Danielle S. J. Milanez, Flávia M. Silva
Nutrition risk is prevalent in intensive care unit (ICU) settings and related to poor prognoses. We aimed to evaluate the concurrent and predictive validity of different nutrition risk screening tools in the ICU.
-
Intestinal failure–associated liver disease: Current challenges in screening, diagnosis, and parenteral nutrition considerations Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-01-21 Trevor Tabone, Peter Mooney, Clare Donnellan
Intestinal failure–associated liver disease (IFALD) is a serious life-limiting complication that can occur throughout the clinical course of intestinal failure and its management by parenteral nutrition (PN). Despite this, there is a lack of a standardized definition for IFALD, which makes this insidious condition increasingly difficult to screen and diagnose in clinical practice. Attenuating the progression
-
Nutrition challenges following total pancreatectomy with islet autotransplantation Nutr. Clin. Pract. (IF 3.1) Pub Date : 2024-01-12 Jeanette M. Hasse, Shumei Meng, Stephanie Silpe, Bashoo Naziruddin
Total pancreatectomy with islet autotransplantation (TPIAT) is a surgical treatment option for patients with chronic pancreatitis who have not responded to other therapies. TP offers pain relief whereas IAT preserves beta cell mass to reduce endocrine insufficiency. During the surgical procedure, the entire pancreas is removed. Islet cells from the pancreas are then isolated, purified, and infused
-
Evaluation of different screening tools as the first step of the GLIM framework: A cross-sectional study of Chinese cancer patients in an outpatient setting Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-31 Yanfei Wang, Ziqi Liu, Hong Zhang, Yunyi Wang, Xiaoyan Chen, Wenqi Lu, Yu Fang, Zhi Peng, Wei Liu
Ambulatory cancer patients are at high risk of malnutrition. Multiple nutrition screening and assessment tools are used in the outpatient setting. This study aimed to evaluate the efficacy of different nutrition screening tools as the first step of the Global Leadership Initiative on Malnutrition (GLIM) framework in Chinese ambulatory cancer patients.
-
Improving anthropometric measurements in hospitalized children: A quality-improvement project Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-28 Sabrina Persaud, Bridget M. Hron, Coral Rudie, Patricia Mantell, Prerna S. Kahlon, Katelyn Ariagno, Al Ozonoff, Shrunjal Trivedi, Carlos Yugar, Nilesh M. Mehta, Michelle Raymond, Christopher P. Duggan, Susanna Y. Huh
The objective of this quality-improvement project was to increase documentation rates of anthropometrics (measured weight, length/height, and body mass index [BMI], which are critical to identify patients at malnutrition (undernutrition) risk) from <50% to 80% within 24 hours of hospital admission for pediatric patients.
-
The association between sarcopenia, defined by a simplified screening tool, and long-term outcomes Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-26 Thassayu Yuyen, Weerasak Muangpaisan, Pornpoj Pramyothin, Chayanan Thanakiattiwibun, Onuma Chaiwat
Sarcopenia and frailty are frequently observed in older adult patients and linked to unfavorable postoperative outcomes. Identifying low muscle mass and function is primary for diagnosing sarcopenia. The simpler screening, which excludes muscle mass measurement, exhibited strong predictive capabilities in identifying sarcopenia. This research explored the association between sarcopenia, as defined
-
Measuring body composition in pediatric patients with complex diagnoses: Acceptability, practicality, and validation of different techniques Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-24 Nara E. Lara-Pompa, Sarah Macdonald, Katherine Fawbert, Vanessa Shaw, Jonathan C. Wells, Mary Fewtrell, Susan Hill
Body composition could help identify malnutrition in pediatric patients, but there is uncertainty over which techniques are most suitable and prevailing opinion that measurements are difficult to obtain in practice. This study examined the acceptability, practicality, reliability, and validity of different anthropometric and body composition measurements in patients with complex diagnoses in a tertiary
-
Cannabis use in the United States and its impact on gastrointestinal health Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-23 Omayma Alshaarawy, Gokulakrishnan Balasubramanian, Thangam Venkatesan
In recent years, the legalization and social acceptability of cannabis use have increased in the United States. Concurrently, the prevalence of cannabis use has continued to rise, and cannabis products have diversified. There are growing concerns regarding the health effects of regular and high-potency cannabis use, and new research has shed light on its potentially negative effects. Here, we review
-
Parenteral nutrition insecurity: ASPEN survey to assess the extent and severity of parenteral nutrition access and reimbursement issues Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-16 Jay M. Mirtallo, Allison Blackmer, Kathryn Hennessy, Penny Allen, Alaa D. Nawaya
Parenteral nutrition (PN) shortages and lack of qualified professional staff to manage PN impact safe, efficacious care and costs of PN. This American Society for Parenteral and Enteral Nutrition (ASPEN)–sponsored survey assessed the frequency and extent to which PN access affects PN delivery to patients.
-
Assessing nutrition status, sarcopenia, and frailty in adult transplant recipients Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-14 Astrid Ruiz-Margáin, Ricardo U. Macías-Rodríguez, Nayelli C. Flores-García, Berenice M. Román Calleja, Oscar M. Fierro-Angulo, José A. González-Regueiro
The assessment of nutrition status, sarcopenia, and frailty holds significant relevance in the context of adult transplantation, as these factors are associated with an unfavorable prognosis; thus, transplant candidates must undergo a full nutrition assessment. Screening tools may be used to prioritize patients, this can be done using the Nutrition Risk Screening 2002 or Royal Free Hospital-Nutritional
-
Malnutrition, sarcopenia, and frailty assessment in pediatric transplantation Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-13 Stacey Silver Beer, Molly Wong Vega
Nutrition assessment can be challenging in children with end-stage organ disease and in those requiring an organ transplant. The effect of poor nutrition status can exert long-lasting effects on children with end-stage organ disease requiring transplantation. Malnutrition, sarcopenia, and frailty are conditions that require provision of optimal nutrition to prevent or support the treatment of these
-
Nutrition support management of organ transplant recipients in the acute posttransplant phase Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-11 Michaelann Hahn, Abby Wood, Jeanette M. Hasse
Patients who undergo solid organ transplant can have an extensive and challenging postoperative course. The chronicity of the disease state prior to transplant in combination with transplant-specific complications and immunosuppressant medications can lead to distinct challenges that are not observed in other critically ill patients. Although the manifestation of posttransplant complications may be
-
Nutrition support in the pediatric total pancreatectomy with islet autotransplantation recipient Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-10 Elissa M. Downs, Amanda Brun, Melena D. Bellin
For children with diminished quality of life and chronic pain caused by acute recurrent or chronic pancreatitis who are undergoing total pancreatectomy with islet autotransplantation, postoperative nutrition support has several unique characteristics. Surgical complications may lead to delays in nutrition support initiation or require modifications to the regimen. Early postoperative dysmotility requires
-
Nutrition care for the adult post–intestinal transplant patient Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-09 Lindsay Dowhan, Lisa Moccia, Masato Fujiki
Intestinal transplantation has emerged as an accepted treatment choice for individuals experiencing irreversible intestinal failure. This treatment is particularly relevant for those who are not candidates or have poor response to autologous gut reconstruction or trophic hormone therapy, and who can no longer be sustained on parenteral nutrition. One of the main goals of transplant is to eliminate
-
Amplifying the lived experiences of parenteral nutrition consumers through the thematic analysis of social media posts Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-08 Regina Barrera, Kristy Poindexter, Chandler Tucker, Marion F. Winkler, Hassan S. Dashti
Consumers of parenteral nutrition (PN) and their caregivers use social media to seek advice and support from their peers and to share experiences. We aimed to leverage posts from a social media patient community to identify common lived experiences of consumers of PN to prioritize opportunities for support through advocacy, education, and research.
-
Explanatory sequential mixed-methods approach to understand how registered dietitians implemented computed tomography skeletal muscle assessments in clinical practice Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-12-04 Lisa Martin, Mei Tom, Carlota Basualdo-Hammond, Vickie E. Baracos, Leah Gramlich
There is a need to adopt valid techniques to assess skeletal muscle (SM) in clinical practice. SM can be precisely quantified from computed tomography (CT) images. This study describes how registered dietitians (RDs), trained to quantify SM from CT images, implemented this technique in clinical practice.
-
Effect of vitamin A on maternal, fetal, and neonatal outcomes: An overview of deficiency, excessive intake, and intake recommendations Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-29 Muhammad Umer Ishaq, Digbijay Kunwar, Abdul Qadeer, Aqsa Komel, Adnan Safi, Aqsa Malik, Linta Malik, Anum Akbar
Vitamin A imbalance during pregnancy and lactation is a global public health concern with potentially negative consequences for fetuses and neonates. Inadequate vitamin A intake during this critical period can lead to anemia, weakened immune function, night blindness, and increased susceptibility to infections. Conversely, excessive intake of vitamin A can result in birth defects, hypercalcemia, and
-
Treatment of refractory shock with vitamin B12: A narrative review Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-29 Courtney Wedemire, Hamed Samavat, Melanie Newkirk, Anna Parker
High-dose vitamin B12 is a potential treatment for patients with vasodilatory shock that is refractory to other therapies. Vasodilatory shock is characterized by low blood pressure and low systemic vascular resistance. Nitric oxide and hydrogen sulfide, two potential targets of high-dose vitamin B12 given as hydroxocobalamin, facilitate this syndrome. This review explores the relationship between high-dose
-
Immunosuppression in solid organ–transplant recipients and impact on nutrition support Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-29 Nicole K. Wilson, Ann D. Kataria
A key component to nutrition support is to consider immunosuppressive agents, the interaction with nutrients, and how the side effects of the medications influence nutrition support. The immunosuppression of the solid organ–transplant recipient involves the individualized titration of multiple therapeutic agents to prevent allorecognition and, thus, rejection of the transplanted organ. Induction immunosuppression
-
Standardizing vitamin D supplementation to minimize deficiency in children with intestinal failure Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-29 Jade Zhong, Debby S. Martins, Hannah G. Piper
Vitamin D deficiency is present in 40%–70% of children with intestinal failure (IF), yet there are no published guidelines for repleting and maintaining vitamin D levels in this population. The purpose of this study is to evaluate the efficacy of a standardized vitamin D algorithm in reducing the incidence of deficiency.
-
Musings on the evolution of transplant nutrition or "If we only knew then what we know now". Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-28 Sara R DiCecco
-
The importance of providing dietary fiber in medical and surgical critical care Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-10 Stephen A. McClave, Endashaw Omer, Mohamed Eisa, Abby Klosterbauer, Cynthia C. Lowen, Robert G. Martindale
The early provision of soluble/insoluble fiber to the patient who is critically ill has been controversial in the past. Especially in the setting of hemodynamic instability, dysmotility, or impaired gastrointestinal transit, fear of inspissation of formula with precipitation of nonocclusive mesenteric ischemia (NOMI)/nonocclusive bowel necrosis (NOBN) limited its utilization by medical and surgical
-
ENFit does not connect as a safety design: Response to Troubleshooting pediatric gastrostomy - ENFit inaccuracies. Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-06 Thane Blinman,Dennis Hiller
-
Calf circumference predicts sarcopenia in maintenance hemodialysis Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-06 Berşan Özcan, Merve Güner, Serdar Ceylan, Yelda Öztürk, Sinem Girgin, Arzu Okyar Baş, Meltem Koca, Cafer Balcı, Burcu Balam Doğu, Mustafa Cankurtaran, Tolga Yıldırım, Meltem Gülhan Halil
Early recognition of sarcopenia in hemodialysis (HD) patients will be of great importance in preventing adverse outcomes and improving the quality of life in these patients. The main goal of this study was to evaluate the diagnostic accuracy of calf circumference (CC) measurement in detecting sarcopenia among CKD patients undergoing maintenance HD.
-
Unveiling the impact of immunonutrition and BMI on cancer outcomes: A complex connection worthy of in-depth investigation. Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-05 Suhani Ghai
-
Nutrition support considerations in pediatric small bowel transplantation Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-11-05 Anita M. Nucci, Kathleen Crim, Elizabeth King, Armando J. Ganoza, Lisa Remaley, Jeffrey Rudolph
Enteral autonomy is the primary goal of intestinal failure therapy. Intestinal transplantation (ITx) is an option when enteral autonomy cannot be achieved and management complications become life-threatening. The purpose of this review is to summarize existing medical literature related to nutrition requirements, nutrition status, and nutrition support after pediatric ITx. Achieving or maintaining
-
Sustained elimination of parenteral support in adult patients with under 60 cm of small intestine: A case series Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-10-29 Hilary Catron, Corrine Hanson, Laura Beerman, Jaime Carney, Kathryn Janiak, Brandi Gerhardt, Fedja Rochling, David Mercer
Patients with short bowel syndrome (SBS) are often managed by expert multidisciplinary teams. One of the main goals in the management of SBS is the weaning of parenteral support (PS). Weaning of PS removes the risks associated with long-term central line placement and eliminates the need for intestinal transplant. Whereas several papers detail the ongoing care and management of patients with SBS who
-
Nutrition determinants of acute skeletal muscle loss in critically ill patients: A prospective observational cohort study Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-10-25 Melda Kangalgil, Ahmet Oğuzhan Küçük, Hülya Ulusoy, Ayşe Özfer Özçelik
Skeletal muscle loss is associated with adverse outcomes in critically ill patients and risk factors of acute skeletal muscle loss are not well described. This study aims to determine the factors associated with acute skeletal muscle loss in critically ill patients.
-
Relationship among low baseline muscle mass, skeletal muscle quality, and mortality in critically ill children Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-10-24 Yang Xue, Tian-Tian Wang, Lei Zhang, Shuang Zheng, Yue-Ming Mu, Fei-Yong Jia, Lin Du
Studies in adults have shown that low baseline muscle mass at intensive care unit (ICU) admission was associated with poor clinical outcomes. However, no information on the relationship between baseline muscle quality or mass and clinical outcomes in critically ill children was found.
-
Clinical outcomes associated with blenderized tube feedings in adults: A systematic review Nutr. Clin. Pract. (IF 3.1) Pub Date : 2023-10-22 Erin R. Schultz, Yeonsoo Kim
Nearly half a million individuals in the United States are dependent on enteral nutrition to meet their nutrition needs. Public interest in blenderized tube feeding (BTF) has increased over the past decade; however, medical professionals indicate a lack of knowledge about these products and their effects. The purpose of this review is to analyze clinical outcomes in adults who use a BTF formula as